Dupilumab Improves Symptom Control, Health-Related Quality of Life and Work Productivity Among Adults With Moderate-to-Severe Atopic Dermatitis in Clinical Practice: 6-Year Follow-Up Results From the RELIEVE-AD Study. J of Skin [Internet]. 2025 Nov. 10 [cited 2026 Apr. 21];9(6):s598. Available from: https://skin.dermsquared.com/skin/article/view/3844